133 related articles for article (PubMed ID: 447017)
1. Hepatic circulation and drug disposition in cirrhosis.
Shand DG
Gastroenterology; 1979 Jul; 77(1):185-6. PubMed ID: 447017
[No Abstract] [Full Text] [Related]
2. Drug disposition in liver disease.
Fruncillo RJ
Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
[No Abstract] [Full Text] [Related]
3. Drug disposition in liver disease.
Shand DG
N Engl J Med; 1977 Jun; 296(26):1527-8. PubMed ID: 865536
[No Abstract] [Full Text] [Related]
4. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
Larrey D; Branch RA
Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
[No Abstract] [Full Text] [Related]
5. [Theophylline pharmacokinetics in patients with liver diseases with reference to estimated hepatic blood flow].
Nomura F; Ohnishi K; Ohto M; Takeda Y; Rikihisa T; Kanakubo Y
Rinsho Byori; 1991 Oct; 39(10):1093-7. PubMed ID: 1762184
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic study on the hepatic uptake of indocyanine green in cirrhotic patients.
Kawasaki S; Sugiyama Y; Iga T; Hanano M; Sanjo K; Beppu T; Idezuki Y
Am J Gastroenterol; 1985 Oct; 80(10):801-6. PubMed ID: 4036939
[TBL] [Abstract][Full Text] [Related]
7. [Prescription of drugs in liver diseases].
Held H
Internist (Berl); 1980 Dec; 21(12):724-34. PubMed ID: 7009474
[No Abstract] [Full Text] [Related]
8. A new model-independent physiological approach to study hepatic drug clearance and its applications.
Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
[TBL] [Abstract][Full Text] [Related]
9. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A
Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
[TBL] [Abstract][Full Text] [Related]
10. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
[TBL] [Abstract][Full Text] [Related]
11. Clearance and biologic half-life as indices of intrinsic hepatic metabolism.
Perrier D; Gibaldi M
J Pharmacol Exp Ther; 1974 Oct; 191(1):17-24. PubMed ID: 4423599
[No Abstract] [Full Text] [Related]
12. [Handling of drugs by cirrhotic patients].
Danan G; Pariente A
Rev Prat; 1986 Sep; 36(39):2298-308. PubMed ID: 3809928
[No Abstract] [Full Text] [Related]
13. [Drug dosing in chronic hepatic disease (author's transl)].
Gugler R; Eichelbaum M
Leber Magen Darm; 1981 Apr; 11(2):81-7. PubMed ID: 7015045
[TBL] [Abstract][Full Text] [Related]
14. Misuse of the well-stirred model of hepatic drug clearance.
Yang J; Jamei M; Yeo KR; Rostami-Hodjegan A; Tucker GT
Drug Metab Dispos; 2007 Mar; 35(3):501-2. PubMed ID: 17325025
[No Abstract] [Full Text] [Related]
15. Drug disposition and dosing in hepatic disease.
Somogyi A; Rolan P
Med J Aust; 1986 Sep; 145(6):284-6, 289. PubMed ID: 3747914
[No Abstract] [Full Text] [Related]
16. [Side effects of drugs--predictable hazards for patients with liver disease].
Baumgarten R
Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
[No Abstract] [Full Text] [Related]
17. [Role of clinical pharmacokinetics in the causal treatment of acute drug poisoning].
Lesne M
Bull Mem Acad R Med Belg; 1981; 136(8-9):443-72. PubMed ID: 7042014
[No Abstract] [Full Text] [Related]
18. [The metabolic clearance rate of antipyrine: a good index for the assessment of the hepatic drug-oxidizing function in cirrhotic patients (author's transl)].
Miguet JP; Allemand H; Joanne C; Dhumeaux D
Nouv Presse Med; 1978 Dec; 7(46):4209-11. PubMed ID: 745958
[No Abstract] [Full Text] [Related]
19. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
Meijer DK; van der Sluijs P
Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
[No Abstract] [Full Text] [Related]
20. Effective liver blood flow: determination by galactose clearance.
Henderson JM; Hanna SS
Can J Surg; 1983 Mar; 26(2):129-32. PubMed ID: 6824999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
